Patient Capital Management’s The RealReal REAL Stock Holding History

Patient Capital Management’s Portfolio REAL Stock Details REAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-173,500	Closed	-$2.01M	–	47
2021 Q4	$2.01M	Buy	+173,500	New	+$2.28M	0.58%	41

Other funds holding REAL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Patient Capital Management's REAL Position: Q1 2022 in Review

Patient Capital Management sold out of The RealReal (REAL) in Q1 2022, closing a stake of 173,500 shares — an estimated $2.01M sold.

Patient Capital Management first reported a position in REAL in Q4 2021 and held it in 1 quarter. The position peaked at $2.01M in Q4 2021. 184 funds tracked by Wall St. Rank hold REAL as of Q1 2022.

Patient Capital Management reported no remaining The RealReal position as of Q1 2022 after selling out during the quarter.
Patient Capital Management sold 173,500 The RealReal shares in Q1 2022, an estimated $2.01M.
Patient Capital Management first reported a position in The RealReal in Q4 2021 and held it in 1 quarter.
Patient Capital Management's The RealReal position peaked at $2.01M in Q4 2021.
184 funds tracked by Wall St. Rank held The RealReal as of Q1 2022.

Based on Patient Capital Management's 13F filing for Q1 2022, filed 16 May 2022.